Cardiac rhythm devices in the pediatric population: Utilization and complications

被引:46
作者
Czosek, Richard J. [1 ]
Meganathan, Karthikeyan [2 ]
Anderson, Jeffrey B. [1 ]
Knilans, Timothy K. [1 ]
Marino, Bradley S. [1 ]
Heaton, Pamela C. [3 ]
机构
[1] Cincinnati Childrens Hosp Med Ctr, Inst Heart, Dept Pediat, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Dept Publ Hlth Sci, Cincinnati, OH USA
[3] Univ Cincinnati, Coll Pharm, Div Pharm Practice & Adm Sci, Cincinnati, OH 45267 USA
关键词
Pediatric; Electrophysiology; Cardiology; Pacemaker; Defibrillator; Complications; United States; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; CONGENITAL HEART-DISEASE; HYPERTROPHIC CARDIOMYOPATHY; DEATH; THERAPY; YOUNG; PREVENTION; EXPERIENCE; PACEMAKERS; REGISTRY;
D O I
10.1016/j.hrthm.2011.09.004
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
BACKGROUND Cardiac rhythm devices are important in the management of pediatric patients with rhythm abnormalities, although factors driving utilization are poorly understood. OBJECTIVE This study sought to evaluate utilization trends, complication rates, and cost associated with device implantation in the pediatric population. METHODS Device implantation was analyzed using the Kids' Inpatient Database from 1997 to 2006. The type of device implantation, patient demographics, hospital characteristics, acute in-hospital complications, cost, and length of stay (LOS) were analyzed. chi(2) tests were used to test association between categorical variables, and logistic regression analysis was performed to evaluate risk factors associated with complications. RESULTS There were 5788 hospitalizations with device implantations. Although there was a significant increase in defibrillator implantation, there was no significant increase in the number of pacemaker implantations over this time period. Patient-and device-related complications were relatively common in all device cohorts (pacemaker 11.2%, 7.2%; defibrillator 5.9%, 11.5%; and biventricular device 19.4%, 26.7%). Type of complication was dependent on device type. Increased risk of complication was evident in the pacemaker cohort, patients with congenital heart disease, cardiomyopathy, previous cardiac arrest, and other heart operations. Patient-related complications increased cost and LOS regardless of patient or procedural characteristics. Device implantation in patients <5 years old was associated with increased LOS and cost but was not associated with increased risk of complication. CONCLUSION Device utilization in pediatrics is increasing due to escalating defibrillator implantation and biventricular pacing. Cost and LOS are significantly increased by patient complications. Reduction in these complications would improve patient care and lower medical costs.
引用
收藏
页码:199 / 208
页数:10
相关论文
共 21 条
[1]
Agency for Healthcare Research and Quality, 2009, HCUP KID DAT DOC
[2]
Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics [J].
Alexander, ME ;
Cecchin, F ;
Walsh, EP ;
Triedman, JK ;
Bevilacqua, LM ;
Berul, CI .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2004, 15 (01) :72-76
[3]
Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy [J].
Begley, DA ;
Mohiddin, SA ;
Tripodi, D ;
Winkler, JB ;
Fananapazir, L .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2003, 26 (09) :1887-1896
[4]
Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients [J].
Berul, Charles I. ;
Van Hare, George F. ;
Kertesz, Naomi J. ;
Dubin, Anne M. ;
Cecchin, Frank ;
Collins, Kathryn K. ;
Cannon, Bryan C. ;
Alexander, Mark E. ;
Triedman, John K. ;
Walsh, Edward P. ;
Friedman, Richard A. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (17) :1685-1691
[5]
Defibrillator indications and implantation in young children [J].
Berul, Chartes I. .
HEART RHYTHM, 2008, 5 (12) :1755-1757
[6]
Burns KM, HEART RHYTHM, V8, P23
[7]
Cardiac Resynchronization Therapy (and Multisite Pacing) in Pediatrics and Congenital Heart Disease: Five Years Experience in a Single Institution [J].
Cecchin, Frank ;
Frangini, Patricia A. ;
Brown, David W. ;
Fynn-Thompson, Francis ;
Alexander, Mark E. ;
Triedman, John K. ;
Gauvreau, Kimberlee ;
Walsh, Edward P. ;
Berul, Charles I. .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2009, 20 (01) :58-65
[8]
Role of transvenous Implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults [J].
Chatrath, R ;
Porter, CBJ ;
Ackerman, MJ .
MAYO CLINIC PROCEEDINGS, 2002, 77 (03) :226-231
[9]
Pacing treatment for dilated cardiomyopathy: optimization of resynchronization pacing in pediatrics [J].
Greene, E. Anne ;
Berul, Charles I. .
CURRENT OPINION IN CARDIOLOGY, 2010, 25 (02) :95-101
[10]
Implantable cardioverter-defibrillators in tetralogy of Fallot [J].
Khairy, Paul ;
Harris, Louise ;
Landzberg, Michael J. ;
Viswanathan, Sangeetha ;
Barlow, Amanda ;
Gatzoulis, Michael A. ;
Fernandes, Susan M. ;
Beauchesne, Luc ;
Therrien, Judith ;
Chetaille, Philippe ;
Gordon, Elaine ;
Muhll, Isabelle Vonder ;
Cecchin, Frank .
CIRCULATION, 2008, 117 (03) :363-370